Mandatory conversion of Secured Convertible Notes due 2029
Company: Core Scientific
What the later record shows
Delivered on time · happened July 10, 2024
The 10-K states that the $260.0 million New Secured Convertible Notes due 2029 were mandatorily converted as of July 10, 2024 and are no longer outstanding. This matches the promised date.
“The Company issued $ 260.0 million aggregate principal amount of secured convertible notes due 2029 (the “New Secured Convertible Notes”) pursuant to a secured convertible notes indenture”
2026-03-01 · Core Scientific 10-K filed 2026-03-02 View cached copy (2026-08-31)Live source ↗
“The New Secured Convertible Notes were mandatorily converted as of July 10, 2024, and are no longer outstanding.”
2026-03-01 · Core Scientific 10-K filed 2026-03-02 View cached copy (2026-08-31)Live source ↗
Checked November 1, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
Core Scientific announced the mandatory conversion of its outstanding Secured Convertible Notes due 2029, to take place on July 10, 2024 at a conversion price of $5.8317 per share, eliminating $260 million of debt from its balance sheet.
Source (primary)
core-scientific 8-K exhibit (finalcorzconversionpressre.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-01)Live source ↗
Quote: “In connection with the mandatory conversion of the Notes, which will take place on July 10, 2024, each registered holder of the Notes is entitled to receive (1) a number of shares of the Company's common stock equal to the aggregate principal amount of his, her or its Notes outstanding, divided by the conversion price of $5.8317”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms core-scientific 8-K exhibit (finalcorzconversionpressre.htm)
Quote: “In connection with the mandatory conversion of the Notes, which will take place on July 10, 2024, each registered holder of the Notes is entitled to receive (1) a number of shares of the Company's common stock equal to the aggregate principal amount of his, her or its Notes outstanding, divided by the conversion price of $5.8317”
confirms Core Scientific 10-K filed 2026-03-02
Quote: “The Company issued $ 260.0 million aggregate principal amount of secured convertible notes due 2029 (the “New Secured Convertible Notes”) pursuant to a secured convertible notes indenture”